Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended	6 Months Ended
Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues:
Premiums	$ 63,896	$ 56,233	$ 127,966	$ 111,719
Investment and other income	295	556	662	1,008
Total revenues	80,332	71,321	160,481	141,517
Operating costs:
Medical costs	52,093	46,546	104,616	91,450
Operating costs	11,709	10,359	23,110	20,582
Cost of products sold	8,596	7,660	17,083	15,232
Depreciation and amortization	802	778	1,590	1,536
Total operating costs	73,200	65,343	146,399	128,800
Earnings from operations	7,132	5,978	14,082	12,717
Interest expense	(467)	(410)	(900)	(807)
Earnings before income taxes	6,665	5,568	13,182	11,910
Provision for income taxes	(1,466)	(1,196)	(2,835)	(2,560)
Net earnings	5,199	4,372	10,347	9,350
Earnings attributable to noncontrolling interests	(129)	(106)	(250)	(222)
Net earnings attributable to UnitedHealth Group common shareholders	$ 5,070	$ 4,266	$ 10,097	$ 9,128
Earnings per share attributable to UnitedHealth Group common shareholders:
Basic	$ 5.41	$ 4.52	$ 10.75	$ 9.66
Diluted	$ 5.34	$ 4.46	$ 10.61	$ 9.55
Basic weighted-average number of common shares outstanding	937	944	939	945
Dilutive effect of common share equivalents	13	12	13	11
Diluted weighted-average number of common shares outstanding	950	956	952	956
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	3	1	3	2
Products
Revenue from Products and Services	$ 9,496	$ 8,433	$ 18,836	$ 16,773
Services
Revenue from Products and Services	$ 6,645	$ 6,099	$ 13,017	$ 12,017

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227